Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

Morie A. Gertz; Francis K. Buadi; Suzanne R. Hayman; Martha Q. Lacy; Angela Dispenzieri; David Dingli; Wilson I. Gonsalves; Shaji Kumar; Prashant Kapoor; Taxiarchis Kourelis; William J. Hogan

doi:10.1016/j.mayocp.2017.09.012

Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Wilson I. Gonsalves, Shaji Kumar, Prashant Kapoor, Taxiarchis Kourelis, William J. Hogan

Hematology

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.

Original language	English (US)
Pages (from-to)	56-58
Number of pages	3
Journal	Mayo Clinic proceedings
Volume	93
Issue number	1
DOIs	https://doi.org/10.1016/j.mayocp.2017.09.012
State	Published - Jan 2018

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2017.09.012

Cite this

@article{e140506f37774aafa5c48625faa1c240,

title = "Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma",

abstract = "Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.",

author = "Gertz, {Morie A.} and Buadi, {Francis K.} and Hayman, {Suzanne R.} and Lacy, {Martha Q.} and Angela Dispenzieri and David Dingli and Gonsalves, {Wilson I.} and Shaji Kumar and Prashant Kapoor and Taxiarchis Kourelis and Hogan, {William J.}",

note = "Publisher Copyright: {\textcopyright} 2017 Mayo Foundation for Medical Education and Research",

year = "2018",

month = jan,

doi = "10.1016/j.mayocp.2017.09.012",

language = "English (US)",

volume = "93",

pages = "56--58",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "1",

}

TY - JOUR

T1 - Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

AU - Gertz, Morie A.

AU - Buadi, Francis K.

AU - Hayman, Suzanne R.

AU - Lacy, Martha Q.

AU - Dispenzieri, Angela

AU - Dingli, David

AU - Gonsalves, Wilson I.

AU - Kumar, Shaji

AU - Kapoor, Prashant

AU - Kourelis, Taxiarchis

AU - Hogan, William J.

PY - 2018/1

Y1 - 2018/1

N2 - Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.

AB - Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.

UR - http://www.scopus.com/inward/record.url?scp=85040560203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040560203&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.09.012

DO - 10.1016/j.mayocp.2017.09.012

M3 - Article

C2 - 29304921

AN - SCOPUS:85040560203

SN - 0025-6196

VL - 93

SP - 56

EP - 58

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 1

ER -

Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this